Chasing the Biopharma Market: From New Customer Bases and Vaccines to Biosimilars and Antibodies
By Cytiva (formerly GE Life Sciences)Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and manufacture. How can businesses ensure profitability while providing low prices for developing countries?
The growing availability of vaccines over the last century has transformed human health. Without them, we would see a return to almost medieval conditions, where entire populations are devastated by preventable diseases. But we can’t rest on our laurels just yet – there are still improvements to be made.
Related Content
